07/28/2026
Congratulations MCRF team on enrolling the first patient in Iowa in the Evero DCB trial, testing a novel drug coated balloon to reduce the chance of recurrence of a blockage in peripheral artery disease following initial treatment. The study is being conducted at Unitypoint Trinity Medical Center in Bettendorf, Iowa with Dr Nicolas W Shammas, the site principal investigator.